NSE ScannerHospitals & Diagnostics · Hospital/Nursing Management · NSE: JLHL · data 2026-10-30
Jupiter Life Line Hospitals Ltd.
In plain words
Price: 24.4% below its 52-week high of ₹340.
Delivery: 50.0% of traded shares were kept for delivery over the last 10 sessions, against 53.9% over the last 60.
Latest results: a net profit of ₹56 cr for the quarter ended Sept 2026.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹1,621 cr |
| Net profit (last 12 months) | ₹186 cr |
| Sales growth, 3 years (yearly) | 18.9% |
| Profit growth, 3 years (yearly) | 38.6% |
At a glance
Promoters 40.9%, pledged 0.0%, institutions 28.3%.
P/E 45.2, P/B 5.2, dividend yield 0.1%. Price relative to earnings and book value (low is cheaper, not better).
ROE 13.4%, ROCE 13.2%, operating margin 16.0%: how much profit it earns on the money it uses.
Debt/equity 0.38, Profit growth 38.6% and sales growth 18.9% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Profit grew 38.6% a year over 3 years.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q1 FY27)
JLHL Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹410.98 crore, up 18.2% YoY.
Net profit was ₹37.49 crore, down 14.5% YoY.
Operating margin was 19.3% (22.5% a year ago).
EPS was ₹5.72, down 14.5% YoY.
JLHL के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹410.98 करोड़; पिछले साल की तुलना में 18.2% की बढ़त।
शुद्ध मुनाफ़ा: ₹37.49 करोड़; पिछले साल की तुलना में 14.5% की गिरावट।
ऑपरेटिंग मार्जिन: 19.3% (एक साल पहले 22.5%)।
EPS: ₹5.72; पिछले साल की तुलना में 14.5% की गिरावट।
JLHLના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹410.98 કરોડ; ગયા વર્ષની સરખામણીએ 18.2% વધારો.
ચોખ્ખો નફો: ₹37.49 કરોડ; ગયા વર્ષની સરખામણીએ 14.5% ઘટાડો.
ઓપરેટિંગ માર્જિન: 19.3% (એક વર્ષ પહેલાં 22.5%).
EPS: ₹5.72; ગયા વર્ષની સરખામણીએ 14.5% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
12/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Delivery 52.8% over the last 20 sessions vs 58.4% in the 40 before (0.9x); shares delivered per day 0.81x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 7/15: 3 schemes hold it, about ₹634 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results ● Insider ● Split ● Dividend
- 31 Jul 26Results Q1 FY27 results: profit −14.5% YoY -4.0% next session
- 30 Jul 26Insider SAST disclosure: Catalyst Trusteeship Limited acquired shares +1.3% next session
- 29 Jul 26Insider SAST disclosure: Catalyst Trusteeship Limited acquired shares +1.2% next session
- 24 Jul 26Split Split: face value ₹10 → ₹2 (ex-date)
- 22 May 26Dividend Dividend ₹1 (ex-date) +2.9% next session
- 15 May 26Results Q4 FY26 results: profit +12.8% YoY +1.1% next session
- 30 Jan 26Results Q3 FY26 results: profit −19.0% YoY +0.8% next session
- 7 Nov 25Results Q2 FY26 results: profit +11.3% YoY -2.6% next session
- 1 Aug 25Results Q1 FY26 results: profit −1.7% YoY +1.4% next session
- 4 Jul 25Dividend Dividend ₹1 (ex-date) +2.7% next session
- 27 May 25Results Q4 FY25 results: profit −0.9% YoY +1.7% next session
- 7 Feb 25Results Q3 FY25 results: profit +20.2% YoY -6.0% next session
- 8 Nov 24Results Q2 FY25 results: profit +52.9% YoY +6.7% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Sept 2026 | ₹457 cr | ₹56 cr | — | 23.4% | 1.72 |
| Jun 2026 | ₹411 cr | ₹37 cr | — | 19.3% | 5.72 |
| Mar 2025 | ₹327 cr | ₹45 cr | — | 24.0% | 6.84 |
| Jun 2023 | ₹243 cr | ₹54 cr | — | 21.8% | 9.93 |
Shareholding trend
| Holder | Sept 2026 | Mar 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|---|
| Promoters | 40.91% | 40.91% | 40.91% | 40.91% |
| Foreign institutions (FII) | 9.13% | 8.48% | 8.48% | 9.77% |
| Domestic institutions (DII) | 19.13% | 17.01% | 17.43% | 15.82% |
| Mutual funds | 13.45% | 10.97% | 11.55% | 11.05% |
| Retail investors | 1.32% | 1.52% | 1.59% | 1.47% |
| Number of shareholders | 33,255 | 32,985 | 33,620 | 34,192 |
Common questions
What was Jupiter Life Line Hospitals Ltd.'s latest quarterly profit?
Jupiter Life Line Hospitals Ltd. reported a net profit of ₹56 cr for the quarter ended Sept 2026, on revenue of ₹457 cr.
How much do promoters hold in Jupiter Life Line Hospitals Ltd.?
Promoters held 40.91% of Jupiter Life Line Hospitals Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Jupiter Life Line Hospitals Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.38.
What is Jupiter Life Line Hospitals Ltd.'s P/E ratio?
About 45.2, based on the last 12 months' earnings and a price of ₹257.15 (data 2026-10-30).
What is the 52-week high and low of Jupiter Life Line Hospitals Ltd.?
The 52-week high is ₹340 and the 52-week low is ₹233.4.
Mutual funds holding Jupiter Life Line Hospitals Ltd.
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 3 schemes holding about ₹634 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| SBI MultiCap Fund | SBI Mutual Fund | 2.09% | ₹490 cr |
| SBI Healthcare Opportunities Fund | SBI Mutual Fund | 2.16% | ₹127 cr |
| ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND | Aditya Birla Sun Life Mutual Fund | 1.55% | ₹17 cr |
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Jupiter Life Line Hospitals Ltd. | ₹257.15 | ₹8,547 cr | 45.2 | 5.2 | 13.4% | 13.2% | 0.38 | -17.5% |
| Park Medi World Limited | ₹219.7 | ₹9,513 cr | — | — | 16.7% | 20.2% | 0.18 | +38.4% |
| Yatharth Hospital and Trauma Care Services Limited | ₹926.9 | ₹8,942 cr | 49.3 | — | 10.4% | 11.6% | 0.15 | +16.3% |
| HealthCare Global Enterprises Ltd. | ₹585.55 | ₹8,731 cr | 375.2 | — | 1.2% | 8.3% | 1.3 | -22.8% |
| Paras Healthcare Limited | ₹740.6 | ₹7,963 cr | — | 18.9 | 13% | 13.8% | 3.53 | +2.9% |
| Kovai Medical Center & Hospital Ltd. | ₹5,816 | ₹6,356 cr | 25.2 | — | 20.3% | 20.6% | 0.31 | +131.5% |
Compare JLHL with PARKHOSPS in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open JLHL in NSE Scanner →